List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 740 studies with search of:   "Melanoma"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Vaccine Therapy in Treating Patients With High-Risk Stage III or Completely Resected Metastatic Melanoma
Conditions: Stage IV Melanoma;   Stage III Melanoma;   Recurrent Melanoma
Interventions: Drug: dendritic cell-gp100-MART-1 antigen vaccine;   Drug: sargramostim
2 Active, not recruiting Phase II Trial of Allovectin-7® for Metastatic Melanoma
Conditions: Melanoma;   Metastatic Melanoma;   Malignant Melanoma;   Skin Cancer
Intervention: Genetic: Allovectin-7®
3 Completed Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma
Conditions: Stage IV Melanoma;   Stage III Melanoma;   Recurrent Melanoma
Intervention: Drug: allovectin-7
4 Not yet recruiting A Safety and Efficacy Study of Intravenous 131I-TM601 in Adult Patients With Malignant Melanoma
Conditions: Melanoma;   Malignant Melanoma;   Metastatic Melanoma
Intervention: Drug: 131I-TM601
5 Completed Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma
Conditions: Stage IV Melanoma;   Stage III Melanoma;   Recurrent Melanoma
Interventions: Drug: allovectin-7;   Drug: allovectin-7/dacarbazine;   Drug: dacarbazine
6 Completed Interferon Beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular Melanoma
Conditions: Intraocular Melanoma;   Melanoma (Skin)
Intervention: Drug: recombinant interferon beta
7 Not yet recruiting Nilotinib in Imatinib(Gleevec) Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged Melanoma
Conditions: Mucosal Melanoma;   Acral Melanoma;   Melanoma
Intervention: Drug: Nilotinib
8 Active, not recruiting Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma
Conditions: Intraocular Melanoma;   Melanoma (Skin)
Interventions: Drug: incomplete Freund's adjuvant;   Drug: multi-epitope melanoma peptide vaccine;   Drug: sargramostim
9 Completed flt3L With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma or Renal Cell Cancer
Conditions: Stage IV Melanoma;   Stage IV Renal Cell Cancer;   Recurrent Renal Cell Cancer;   Recurrent Melanoma
Interventions: Drug: flt3 ligand;   Drug: gp100 antigen;   Drug: MART-1 antigen;   Drug: Montanide ISA-51;   Drug: tyrosinase peptide
10 Active, not recruiting Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
Conditions: Intraocular Melanoma;   Melanoma (Skin)
Interventions: Drug: incomplete Freund's adjuvant;   Drug: multi-epitope melanoma peptide vaccine;   Drug: sargramostim
11 Recruiting Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma
Conditions: Hereditary Melanoma 1 and 2 (cdkn2, cdk4);   Melanoma (Skin)
Interventions: Procedure: gene expression analysis;   Procedure: gene expression profiling;   Procedure: laboratory biomarker analysis;   Procedure: mutation analysis;   Procedure: mutation carrier screening;   Procedure: study of high risk factors
12 Active, not recruiting Study of Temzolomide and Gleevec in Advanced Melanoma
Conditions: Melanoma;   Advanced Melanoma
Intervention: Drug: Gleevec + Temozolomide
13 Not yet recruiting A Study Evaluating Efficacy of ABT-888 in Combination With Temozolomide in Metastatic Melanoma
Conditions: Skin Cancer;   Melanoma;   Metastatic Melanoma
Interventions: Drug: temozolomide;   Drug: ABT-888;   Drug: Placebo
14 Completed Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma
Conditions: Stage IV Melanoma;   Recurrent Melanoma
Interventions: Drug: gp100 antigen;   Drug: interleukin-2
15 Active, not recruiting Vorinostat in Treating Patients With Metastatic or Unresectable Melanoma
Conditions: Intraocular Melanoma;   Melanoma (Skin)
Intervention: Drug: vorinostat
16 Active, not recruiting Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Melanoma
Conditions: Stage IV Melanoma;   Recurrent Melanoma
Interventions: Drug: allogeneic lymphocytes;   Drug: anti-thymocyte globulin;   Drug: cyclophosphamide;   Drug: fludarabine
17 Completed Monoclonal Antibody Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma
Conditions: Intraocular Melanoma;   Melanoma (Skin)
Interventions: Drug: aldesleukin;   Drug: ipilimumab
18 Active, not recruiting FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma
Conditions: Intraocular Melanoma;   Melanoma (Skin)
Intervention: Drug: romidepsin
19 Active, not recruiting AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma
Conditions: Intraocular Melanoma;   Melanoma (Skin)
Intervention: Drug: cediranib maleate
20 Completed Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye Melanoma
Conditions: Intraocular Melanoma;   Melanoma (Skin)
Intervention: Drug: pyrazoloacridine

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services